The Next Generation Bioprinting Market Size is valued projected to record a 29.57 % CAGR during the forecast period for 2023-2031.
Next generation bioprinting also referred as 4D bioprinting, means adding a fourth dimension to these structures so that they can change their shape over time. The fourth dimension of bioprinting technology is made possible by the use of "smart materials," which change when they are exposed to certain stimuli (such as, heat, water, light, electricity, magnetic energy, stress, strain, and pressure). Structures made with next-generation bioprinting can change shape, but they can also fix themselves and adapt to changes in their environment.
This also includes printing the materials that respond to stimuli and making them work better with bio-inks. Deformed structures made with 4D printing are also hard to put together and fold. 4D bioprinting is getting a lot of attention from both academics and businesspeople. In fact, the amount of related scientific literature has grown by about 130% in the last five years, which shows how popular 4D bioprinting is becoming.
The biomedical industry has greatly benefited from the development of 4D bioprinting or next generation bioprinting technology, particularly in the areas of dentistry, scaffolds, and tissue engineering (TE). This stimulates the market and aids in its expansion overall. Any organ or tissue regeneration that occurs accidentally needs to be replaced. In the end, these factors encourage scientists to consider developing artificial tissues and organs that utilise living cells.
These circumstances will drive the market with research and advancements in bioprinting technology, which is based on bioprinters that can replicate stem cells and organs exactly. Additionally, the market share will increase in the upcoming years due to an increase in start-ups, the expanding use of 4D bioprinting for applications including tissue engineering, regenerative medicine, and medicinal applications, as well as an increase in stakeholder interest in technical breakthroughs.
However, expensive development costs, stringent regulatory restrictions for implantable devices and smart materials used in the product, as well as low awareness in low- and middle-income nations, are some of the reasons impeding market growth.
Market Segmentation:
The next generation bioprinting market is segmented into three main categories Type of Technology, Application Area and End-User. By the type of technology, it comprises Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology and Others. The application area includes Biomedical Applications and Others. The third segment End-User has Pharmaceutical and Biotechnology Companies, Academic Research and Development Other and End-users.
The North American region will probably dominate the global next generation bioprinting market. North America's primary dominant factors are new innovations and research, cooperation for development, and big investments in the region.
Competitive Landscape:
Some of The Key Players in The Next Generation Bioprinting Market:
- DirectSync Surgical
- Poietis
- Regenhu
- 3D Systems, Inc.
- GeSiM
- Stratasys
- ROKIT Healthcare
- Sculpteo
- Smart3D
- VIVAX BIO
- EnvisionTec
- EOS GmbH Electro Optical System
- Materialise NV
- Dassault Systèmes
- Organovo Holdings, Inc.
- CellLink
- Izumi International, Inc
- Advanced Solutions Life Sciences. LLC.
The Next Generation Bioprinting Market Report Scope:
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 29.57 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type of Technology, By Application, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
DirectSync Surgical, Poietis, 3D Systems, Inc., GeSiM, Regenhu, ROKIT Healthcare, Sculpteo, Smart3D, Stratasys, VIVAX BIO, EnvisionTec, EOS GmbH Electro Optical System, Materialise NV, Dassault Systèmes, Organovo Holdings, Inc., CellLink, Izumi International, Inc, Advanced Solutions Life Sciences. LLC and other market players. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
